13,750,000 Shares TherapeuticsMD, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • September 25th, 2013 • TherapeuticsMD, Inc. • Pharmaceutical preparations • New York
Introductory. TherapeuticsMD, Inc., a Nevada corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 13,750,000 shares of its common stock, par value $0.001 per share (the “Shares”). The 13,750,000 Shares to be sold by the Company are called the “Offered Shares.” Stifel, Nicolaus & Company, Incorporated has agreed to act as the representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares.
